
    
      Advanced cervical cancer patients with metastatic, persistent or recurrent disease after
      radical surgery„ÄÅradical platinum-based concurrent chemoradiotherapy or both will be treated
      by Paclitaxel plus Cisplatin\Carboplatin, PD-L1 antibody Toripalimab and Anlotinib.
    
  